BioAtla, Inc.

BCAB · Nasdaq · SIC 2836: Biological Products, (No Diagnostic Substances) · Market Cap: $0.0B · 41 employees
106
SEC Filings
$2.062228
Close 2026-10-27
41
Employees

Business Summary

BioAtla, Inc. is a clinical-stage biopharmaceutical company developing conditionally active biologic (CAB) antibody-based therapeutics for solid tumor cancers. Its CAB technology exploits pH differences between tumor microenvironments and healthy tissue to selectively bind cancer cells, reducing toxicity. Lead candidates include ozuriftamab vedotin (BA3021), a CAB anti-ROR2 ADC, and BA3182, a CAB-EpCAM x CAB-CD3 bispecific antibody. As of March 2026, the company is exploring strategic options including asset sales and licensing.

Latest Stock Quote

BCAB 2026-10-27 $2.062228 O:$1.95 H:$2.074 L:$1.638 Vol:0.0M VWAP:$1.8841
origin leaf: null

Next Earnings

expected 2026-12-29

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-312025-12-310001193125-26-134499EDGAR102K words
2025-03-282024-12-310000950170-25-046217EDGAR92K words
2024-03-262023-12-310000950170-24-036548EDGAR89K words
2023-03-232022-12-310000950170-23-009551EDGAR94K words
2022-02-282021-12-310000950170-22-002303EDGAR112K words
2021-03-242020-12-310001193125-21-092812EDGAR114K words

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2026-11-162026-09-300001193125-26-462306EDGAR—
2026-08-132026-06-300001193125-26-349542EDGAR68K words
2025-11-132025-09-300001193125-25-280435EDGAR61K words
2025-08-072025-06-300000950170-25-105220EDGAR60K words
2025-05-062025-03-310000950170-25-064594EDGAR56K words
2024-11-072024-09-300000950170-24-123506EDGAR57K words
2024-08-082024-06-300000950170-24-094164EDGAR55K words
2024-05-142024-03-310000950170-24-059757EDGAR52K words
2023-11-072023-09-300000950170-23-060389EDGAR56K words
2023-08-012023-06-300000950170-23-036554EDGAR56K words
2023-05-112023-03-310000950170-23-021358EDGAR54K words
2022-11-042022-09-300000950170-22-022036EDGAR57K words

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-10-200001193125-26-425553EDGAR20K words
2026-09-290001193125-26-407817EDGAR5K words
2026-08-280001539497-26-002373EDGAR1K words
2026-07-160001193125-26-306117EDGAR1K words
2026-04-020001193125-26-140053EDGAR1K words
2026-03-310001193125-26-134501EDGAR3K words
2026-03-230001193125-26-119698EDGAR1K words
2026-03-020001539497-26-000812EDGAR3K words
2026-02-090001193125-26-041852EDGAR1K words
2026-02-060001193125-26-041367EDGAR2K words

106 total filings indexed. 78 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

FDMT — 4D Molecular Therapeutics, Inc. APTN — ADAPTIN BIO, INC. ADMA — ADMA BIOLOGICS, INC. AGEN — AGENUS INC AIM — AIM ImmunoTech Inc. AMGN — AMGEN INC AVXL — ANAVEX LIFE SCIENCES CORP. ARGX — ARGENX SE

Tags

solid-tumor-oncology antibody-drug-conjugates-(adc) t-cell-engaging-bispecific-antibodies immuno-oncology car-t-cell-therapy cab-(conditionally-active-biologics)-technology protein-activated-chemical-switches-(pacs) mmae-payload-with-cleavable-linker sugar-based-linker-(next-generation-cab-adc-platform)

Company Identity

CIK0001826892
TickerBCAB
ExchangeNasdaq
SIC2836: Biological Products, (No Diagnostic Substances)
IncorporatedDE
Websitehttps://www.bioatla.com
Listed2020-12-16

Get More Data

This is a static snapshot. For live, structured JSON with cryptographic provenance chain:

MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp

JSON Profile Stock Quote Origin Record
Origin Provenance
page leaf: 1ba9d3bc9d01d83e33d4378077be0d77e893e946fee742f3eaea7008d80058f8
parent: 47f5d434d2371fda5b5d9f20fb1fccc4e57f7f16704603a0c2ce559f1bd28ee4
content hash: 6cd7b3a6c4b3b7a256c17312379c12284f72546f1cc7580fb0f2bb08dc31331e
signed: 2026-11-16T19:00:53.224Z
sources: 18 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf

Try it — paste this into your AI:

Look up BCAB using the MCP server at origin.rootz.global/mcp. What do their latest SEC filings show?

Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.

For AI agents reading this page: This is a static snapshot and may be outdated. For live data on BCAB, use the Origin MCP server or REST API.
MCP install: claude mcp add origin --transport http https://origin.rootz.global/mcp
API: GET https://origin.rootz.global/api/company/BCAB (~200 tokens, structured JSON with cryptographic provenance)
Tools: origin_company, origin_profile, origin_timeline, origin_filings, origin_quote, origin_transcripts, origin_search, origin_person, origin_skill
Discovery: /.well-known/ai | /llms.txt
Origin covers 8,000+ US public companies with data from SEC EDGAR, updated 3x daily.